ContractRevance Therapeutics, Inc. • February 26th, 2020 • Pharmaceutical preparations
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [*], HAS BEEN OMITTED BECAUSE REVANCE THERAPEUTICS, INC., HAS DETERMINED THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO REVANCE THERAPEUTICS, INC., IF PUBLICLY DISCLOSED.
Caryn G. McDowell Revance Therapeutics, Inc. Re: Separation Agreement Dear Caryn:Revance Therapeutics, Inc. • February 26th, 2020 • Pharmaceutical preparations • California
This letter sets forth the substance of the mutual separation agreement (the “Agreement”) that Revance Therapeutics, Inc. (the “Company”) is offering to you to aid in your employment transition.
EXECUTIVE EMPLOYMENT AGREEMENT forExecutive Employment Agreement • February 26th, 2020 • Revance Therapeutics, Inc. • Pharmaceutical preparations • California
This Executive Employment Agreement (the “Agreement”), made between Revance Therapeutics, Inc. (the “Company”) and Dwight Moxie (“Executive”) (collectively, the “Parties”), is effective as of February 18, 2020 (the “Start Date”).
EXECUTIVE EMPLOYMENT AGREEMENT for Dustin SjutsExecutive Employment Agreement • February 26th, 2020 • Revance Therapeutics, Inc. • Pharmaceutical preparations • California
This Executive Employment Agreement (the "Agreement"), made between Revance Therapeutics, Inc. (the "Company") and Dustin Sjuts ("Executive") (collectively, the "Parties"), is effective as of December 1, 2019 (the "Effective Date").
